Table 2. Associations between the levels of viral antibodies and FSS.
Total FSS scores | Headache and Gastrointestinal complaints | Overtiredness, Dizziness and Musculoskeletal pain | ||
---|---|---|---|---|
HSV1 (AU) | B | -.002 | -.012 | .006 |
95% CI | -.046 to .045 | -.075 to .057 | -.041 to .052 | |
p | .93 | .73 | .80 | |
EBV (AU) | B | -.028 | -.003 | -.034 |
95% CI | -.133 to .068 | -.151 to .143 | -.127 to .059 | |
p | .56 | .80 | .49 | |
CMV (AU) | B | -.004 | .015 | -.016 |
95% CI | -.062 to .055 | -.074 to .106 | -.067 to .039 | |
p | .89 | .72 | .57 | |
HHV6 (AU) | B | -.001 | -.002 | .002 |
95% CI | -.011 to .011 | -.017 to .013 | -.005 to .009 | |
p | .92 | .83 | .52 |
HSV1 = herpes simplex virus type 1 antibody levels in the seropositive group (N = 301), EBV = Epstein barr virus antibody levels in the seropositive group (N = 305), CMV = cytomegalovirus antibody levels in the seropositive group (N = 306), HHV6 = human herpes virus 6 antibody levels in the seropositive group (N = 1117). AU = arbitrary units. All analyses were adjusted for sex, BMI, and affective problems and symptom scores in the other symptom group.